CNVV.F logo

ConvaTec Group PLCOTCPK:CNVV.F Stock Report

Market Cap US$6.3b
Share Price
US$3.48
My Fair Value
AN
AnalystConsensusTarget
US$4.67
25.5% undervalued intrinsic discount
1Y17.5%
7D0%
Portfolio Value
View

ConvaTec Group PLC

OTCPK:CNVV.F Stock Report

Market Cap: US$6.3b

ConvaTec Group (CNVV.F) Stock Overview

Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. More details

CNVV.F fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance5/6
Financial Health4/6
Dividends3/6

CNVV.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

ConvaTec Group PLC Competitors

Price History & Performance

Summary of share price highs, lows and changes for ConvaTec Group
Historical stock prices
Current Share PriceUK£3.48
52 Week HighUK£3.95
52 Week LowUK£2.71
Beta0.71
1 Month Change-0.63%
3 Month Changen/a
1 Year Change17.49%
3 Year Change31.23%
5 Year Change42.54%
Change since IPO8.67%

Recent News & Updates

Recent updates

Shareholder Returns

CNVV.FUS Medical EquipmentUS Market
7D0%-2.3%-0.6%
1Y17.5%5.9%16.8%

Return vs Industry: CNVV.F exceeded the US Medical Equipment industry which returned 5.9% over the past year.

Return vs Market: CNVV.F matched the US Market which returned 16.8% over the past year.

Price Volatility

Is CNVV.F's price volatile compared to industry and market?
CNVV.F volatility
CNVV.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.4%
Market Average Movement6.4%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market3.1%

Stable Share Price: CNVV.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CNVV.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
197810,000Karim Bitarwww.convatecgroup.com

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma.

ConvaTec Group PLC Fundamentals Summary

How do ConvaTec Group's earnings and revenue compare to its market cap?
CNVV.F fundamental statistics
Market capUS$6.30b
Earnings (TTM)US$216.70m
Revenue (TTM)US$2.36b
29.1x
P/E Ratio
2.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNVV.F income statement (TTM)
RevenueUS$2.36b
Cost of RevenueUS$1.03b
Gross ProfitUS$1.32b
Other ExpensesUS$1.10b
EarningsUS$216.70m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Feb 25, 2026

Earnings per share (EPS)0.11
Gross Margin56.09%
Net Profit Margin9.20%
Debt/Equity Ratio69.6%

How did CNVV.F perform over the long term?

See historical performance and comparison

Dividends

2.1%
Current Dividend Yield
61%
Payout Ratio

Does CNVV.F pay a reliable dividends?

See CNVV.F dividend history and benchmarks
When do you need to buy CNVV.F by to receive an upcoming dividend?
ConvaTec Group dividend dates
Ex Dividend DateAug 21 2025
Dividend Pay DateOct 01 2025
Days until Ex dividend19 days
Days until Dividend pay date60 days

Does CNVV.F pay a reliable dividends?

See CNVV.F dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/01 17:47
End of Day Share Price 2025/07/14 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ConvaTec Group PLC is covered by 35 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hassan Al-WakeelBarclays
Samuel EnglandBerenberg
Julien OuaddourBofA Global Research